Bullish
$MDXG, MDXG, Amniofix for OA clearly in the driver's seat with its RMAT designation and the first to complete a BLA. "FDA will not grant an application for a biosimilar for 12 years after the approval of the BLA. • FDA will not accept an application for a biosimilar until 4 years after the BLA was approved " That is money in the bank competitive advantage going forward.
  • 4
  • 2